Month: May 2019

EMD Serono’s Mavenclad Edges Past Novartis’ Gilenya in the Recent Switch Segment of Canada’s Multiple Sclerosis Market, Although Brand Familiarity Remains An Addressable Barrier

EXTON, Pa., May 28, 2019 /PRNewswire/ -- Therapeutic choice for multiple sclerosis (MS) in Canada has expanded substantially over the past...

Calidi Biotherapeutics Announces A Collaborative Study With The National Institutes Of Health (NIH) On The Therapeutic Potential Of Oncolytic Viruses Delivered By Mesenchymal Stem Cells

SAN DIEGO, May 28, 2019 /PRNewswire/ -- Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based...

The Centers for Medicare and Medicaid Services (CMS) Selects CGI to Optimize Cloud Environment, Enhance and Maintain Medicare Advantage and Part D Data Repository

Stock Market SymbolsGIB (NYSE)GIB.A (TSX)www.cgi.com/newsroom Company helps advance healthcare to leverage eGovernment best practices and domain expertise to continue the...

error: Content is protected !!